SPRINT PNS for Post-Amputation Pain

About SPR Therapeutics

SPR Therapeutics is a commercial-stage medical device innovator addressing the critical need for non-opioid chronic pain therapies through its proprietary peripheral nerve stimulation platform. The company's SPRINT® PNS System differentiates itself with a minimally invasive, temporary lead placement and a 60-day treatment regimen, aiming to provide lasting pain relief without permanent implants. Having secured FDA clearances for multiple pain indications, SPR is executing a commercial rollout in the U.S. while continuing to expand its clinical evidence and explore new applications. The company operates in a high-growth market driven by the opioid crisis and demand for effective, non-addictive pain management solutions.

Therapeutic Areas